Bio-Techne Corporation TECH 深 沪
已收盘 02-06 16:00:00 美东时间
66.78
+0.920
+1.40%
华盛通- 最 高67.60
- 今 开66.76
- 成交量 154.71万股
- 最 低 65.845
- 昨 收 65.86
- 总市值 104.48亿
- 52周最高 72.16
- 市盈率 静 145.40
- 换手率 0.99%
- 52周最低 45.77
- 委 比 20.21%
- 总股本 1.56亿
- 历史最高 134.6025
- 量 比 0.44
- 振 幅 2.66%
- 历史最低 11.7725
- 每 手 1
- 风险率 6.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
财报速睇 | Bio-Techne Corporation 2025财年Q4营收2.96亿美元，同比下降0.4%；归母净利润0.38亿美元，同比增长8.9%
华盛资讯2月6日讯，Bio-Techne Corporation公布2025财年Q4业绩，公司Q4营收2.96亿美元，同比下降0.4%，归母净利润0.38亿美元，同比增长8.9%。
02-06 02:48
UBS Maintains Buy on Bio-Techne, Raises Price Target to $79
UBS analyst Dan Leonard maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $70 to $79.
02-05 23:25
财报速睇 | Bio-Techne Corporation 2025财年Q4营收2.96亿美元，同比下降0.4%；归母净利润0.38亿美元，同比增长8.9%
华盛资讯2月5日讯，Bio-Techne Corporation公布2025财年Q4业绩，公司Q4营收2.96亿美元，同比下降0.4%，归母净利润0.38亿美元，同比增长8.9%。
02-05 16:32
Bio-Techne shares are trading higher after the company reported better-than-expected Q2 financial results.
Bio-Techne shares are trading higher after the company reported better-than-exp...
02-05 00:39
Bio-Techne Earnings Review: Q2 Summary
Bio-Techne (NASDAQ:TECH) released its Q2 earnings on Wednesday, February 4, 202...
02-04 20:16
Bio-Techne Earnings Report: Q2 Overview
The earnings results for Bio-Techne (NASDAQ:TECH) for Q2 were made public on We...
02-04 20:04
Bio-Techne: Q2 Earnings Insights
Bio-Techne (NASDAQ:TECH) released its Q2 earnings on Wednesday, February 4, 202...
02-04 19:44
Bio-Techne Q2 Earnings Report: What Investors Need to Know
Bio-Techne (NASDAQ:TECH) just disclosed its Q2 earnings on Wednesday, February ...
02-04 19:38
Bio-Techne posts Q2 adjusted EPS of USD 0.46, up 9.5%
Bio-Techne posts Q2 adjusted EPS of USD 0.46, up 9.5% Bio-Techne Corporation reported its financial results for the second quarter (Q2) of fiscal year 2026. Revenue for the period was USD 295.9 million, with both reported and organic growth flat compared to the prior year. GAAP earnings per share (E
02-04 19:31
